Cargando…

Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment

There is evidence that polymorphonuclear neutrophils (PMNs) can exert severe antineoplastic effects. Cross-talk between tumour cells and endothelial cells (ECs) is necessary for the accumulation of PMN around a tumour. This work reports the ability of two PMN-sensitive, human, permanent cell lines—c...

Descripción completa

Detalles Bibliográficos
Autores principales: Brú, Antonio, Souto, Juan-Carlos, Alcolea, Sonia, Antón, Rosa, Remacha, Angel, Camacho, Mercedes, Soler, Marta, Brú, Isabel, Porres, Amelia, Vila, Luis
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821782/
https://www.ncbi.nlm.nih.gov/pubmed/20169105
http://dx.doi.org/10.1155/2009/817498
_version_ 1782177469761060864
author Brú, Antonio
Souto, Juan-Carlos
Alcolea, Sonia
Antón, Rosa
Remacha, Angel
Camacho, Mercedes
Soler, Marta
Brú, Isabel
Porres, Amelia
Vila, Luis
author_facet Brú, Antonio
Souto, Juan-Carlos
Alcolea, Sonia
Antón, Rosa
Remacha, Angel
Camacho, Mercedes
Soler, Marta
Brú, Isabel
Porres, Amelia
Vila, Luis
author_sort Brú, Antonio
collection PubMed
description There is evidence that polymorphonuclear neutrophils (PMNs) can exert severe antineoplastic effects. Cross-talk between tumour cells and endothelial cells (ECs) is necessary for the accumulation of PMN around a tumour. This work reports the ability of two PMN-sensitive, human, permanent cell lines—colorectal adenocarcinoma (HT-29) and pharyngeal squamous-cell carcinoma (FaDu) cells—to act as inflammatory foci. PMNs were cytotoxic to both lines, the adhesion of the PMNs to the tumour cells being important in this effect. The tumour cells released appreciable amounts of IL-8 and GROα, and induced the transmigration of PMN through human microvascular-EC monolayers. Conditioning media associated with both lines induced the adhesion of PMN and the surface expression of ICAM-1 in microvascular-EC. In addition, FaDu-conditioning-medium strongly induced the production of proinflammatory cytokines by microvascular-EC. These results support the idea that tumour cells might normally induce a potent acute inflammatory response, leading to their own destruction.
format Text
id pubmed-2821782
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-28217822010-02-18 Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment Brú, Antonio Souto, Juan-Carlos Alcolea, Sonia Antón, Rosa Remacha, Angel Camacho, Mercedes Soler, Marta Brú, Isabel Porres, Amelia Vila, Luis Mediators Inflamm Research Article There is evidence that polymorphonuclear neutrophils (PMNs) can exert severe antineoplastic effects. Cross-talk between tumour cells and endothelial cells (ECs) is necessary for the accumulation of PMN around a tumour. This work reports the ability of two PMN-sensitive, human, permanent cell lines—colorectal adenocarcinoma (HT-29) and pharyngeal squamous-cell carcinoma (FaDu) cells—to act as inflammatory foci. PMNs were cytotoxic to both lines, the adhesion of the PMNs to the tumour cells being important in this effect. The tumour cells released appreciable amounts of IL-8 and GROα, and induced the transmigration of PMN through human microvascular-EC monolayers. Conditioning media associated with both lines induced the adhesion of PMN and the surface expression of ICAM-1 in microvascular-EC. In addition, FaDu-conditioning-medium strongly induced the production of proinflammatory cytokines by microvascular-EC. These results support the idea that tumour cells might normally induce a potent acute inflammatory response, leading to their own destruction. Hindawi Publishing Corporation 2009 2010-02-11 /pmc/articles/PMC2821782/ /pubmed/20169105 http://dx.doi.org/10.1155/2009/817498 Text en Copyright © 2009 Antonio Brú et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Brú, Antonio
Souto, Juan-Carlos
Alcolea, Sonia
Antón, Rosa
Remacha, Angel
Camacho, Mercedes
Soler, Marta
Brú, Isabel
Porres, Amelia
Vila, Luis
Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
title Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
title_full Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
title_fullStr Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
title_full_unstemmed Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
title_short Tumour Cell Lines HT-29 and FaDu Produce Proinflammatory Cytokines and Activate Neutrophils In Vitro: Possible Applications for Neutrophil-Based Antitumour Treatment
title_sort tumour cell lines ht-29 and fadu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2821782/
https://www.ncbi.nlm.nih.gov/pubmed/20169105
http://dx.doi.org/10.1155/2009/817498
work_keys_str_mv AT bruantonio tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT soutojuancarlos tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT alcoleasonia tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT antonrosa tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT remachaangel tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT camachomercedes tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT solermarta tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT bruisabel tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT porresamelia tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment
AT vilaluis tumourcelllinesht29andfaduproduceproinflammatorycytokinesandactivateneutrophilsinvitropossibleapplicationsforneutrophilbasedantitumourtreatment